Related by context. All words. (Click for frequent words.) 74 Actemra 73 ACTEMRA TM 73 tocilizumab 72 RoACTEMRA 71 HUMIRA 71 ENBREL 71 adalimumab 71 plus methotrexate 70 Adalimumab 70 etanercept 70 fingolimod 69 CIMZIA TM 69 vandetanib 69 Cimzia ® 69 REMICADE ® 69 certolizumab pegol 69 TYKERB 69 PROMACTA 68 teriflunomide 68 TORISEL 68 abatacept 68 XGEVA 68 placebo controlled clinical 67 PREZISTA r 67 #mg BID [001] 67 Betaferon ® 67 romiplostim 67 Tocilizumab 67 anakinra 67 Torisel 67 active comparator 67 Actemra tocilizumab 67 pertuzumab 67 VELCADE 67 CIMZIA ™ 67 alvimopan 67 lubiprostone 67 mycophenolate mofetil 66 Golimumab 66 posaconazole 66 BRIM2 66 Etanercept 66 eltrombopag 66 ONGLYZA 66 methylnaltrexone 66 Fludara 66 biologic therapy 66 adalimumab Humira 66 lixisenatide 66 tolvaptan 66 JANUVIA 66 rotigotine 66 eculizumab 66 elotuzumab 66 ARCOXIA 66 Vandetanib 66 placebo controlled Phase 66 Keppra R 66 Cimzia R 66 Amrubicin 66 canakinumab 66 TREDAPTIVE 65 Abatacept 65 methotrexate MTX 65 decitabine 65 Cimzia ® certolizumab pegol 65 APTIVUS r 65 NOXAFIL 65 CANCIDAS 65 Dapagliflozin 65 diabetic neuropathic pain 65 cinacalcet 65 CIMZIA 65 Traficet EN 65 Catena ® 65 SEROQUEL 65 Aclasta 65 desvenlafaxine succinate 65 Rivaroxaban 65 Dasatinib 65 CIMZIA TM certolizumab pegol 65 ERBITUX 65 Jevtana 65 lupus nephritis 65 febuxostat 65 HuMax EGFr 65 teriparatide 65 refractory gout 65 icatibant 65 ACZ# 65 COPAXONE R 65 MabCampath 65 PRECiSE 65 INCB# [003] 65 KOMBIGLYZE XR 65 azacitidine 65 SUTENT 64 natalizumab 64 REMICADE 64 Pegasys ® 64 6R BH4 64 nilotinib 64 LymphoStat B 64 ARCALYST 64 FOLFOX 64 Dacogen injection 64 telbivudine 64 relapsing remitting multiple sclerosis 64 ULORIC 64 relapsing multiple sclerosis 64 humanized interleukin 6 64 ORENCIA ® 64 Taxotere ® 64 zolmitriptan 64 Pirfenidone 64 paliperidone ER 64 FOLPI 64 bosentan 64 Abbott HUMIRA 64 AZILECT 64 lacosamide 64 rFVIIa 64 ZOLINZA 64 DOXIL 64 pseudobulbar affect PBA 64 Multaq R 64 PEG INTRON 64 FTY# 64 glatiramer acetate 64 golimumab 64 TYZEKA 64 dasatinib 64 oral FTY# 64 angiotensin receptor blocker ARB 64 sorafenib tablets 64 tipranavir 64 tiotropium 64 palonosetron 64 dapagliflozin 64 chlorambucil 64 oral rivaroxaban 64 AVASTIN 64 rivaroxaban 64 Phenoptin 64 efalizumab 64 SJIA 64 rilonacept 64 ATACAND 64 Cimzia TM 64 placebo controlled Phase III 64 AGILECT ® 64 TELCYTA 64 rheumatoid arthritis RA 64 entecavir 64 RAPTIVA 64 PEGylated anti 64 motavizumab 64 Zenvia Phase III 64 RG# [001] 64 ORENCIA R 64 ISENTRESS 64 Keppra ® 64 roflumilast 63 tanespimycin 63 dyskinesia PD LID 63 active ankylosing spondylitis 63 INTELENCE 63 YERVOY 63 sunitinib malate 63 opioid induced bowel dysfunction 63 achieved ACR# 63 dimebon 63 gout flares 63 ACAPODENE 63 oral anticoagulant 63 elagolix 63 visilizumab 63 DPNP 63 forodesine 63 zoledronic acid 63 venous thromboembolic events 63 Hycamtin 63 DU #b 63 Kepivance 63 REVLIMID lenalidomide 63 Lubiprostone 63 CYPHER ® Stent 63 Rasilez Tekturna 63 Amigal 63 Tarceva erlotinib 63 Noxafil 63 LEXIVA r 63 Increlex ® 63 juvenile idiopathic arthritis 63 Betaferon R 63 darapladib 63 PEG Interferon lambda 63 laquinimod 63 dabigatran etexilate 63 chronic angina 63 heterozygous FH 63 NUVIGIL 63 plus dexamethasone 63 ARIXTRA 63 rosuvastatin #mg 63 bevacizumab Avastin 63 pitavastatin 63 apremilast 63 riociguat 63 sorafenib Nexavar 63 reslizumab 63 saxagliptin 63 AVANDIA 63 Raptiva ® 63 daclizumab 63 baminercept 63 ezogabine 63 events AEs 63 axitinib 63 ADVANCE PD 63 Bevacizumab 63 APTIVUS 63 Mycamine 63 FAMPYRA 63 GSK# [001] 63 infliximab Remicade 63 VAPRISOL 63 AZILECT R 63 STELARA TM 63 rasagiline 63 ASA# 63 aripiprazole Abilify 63 PRISTIQ 63 YONDELIS 63 teduglutide 63 STELARA 63 panitumumab Vectibix 63 DASISION 63 custirsen 63 eosinophilic asthma 63 panitumumab 63 MYCAMINE 63 PEGINTRON 62 ZD# [001] 62 randomized Phase III 62 nab paclitaxel 62 ustekinumab 62 AVELOX 62 Imprime PGG 62 SEROQUEL XR 62 Tarceva TM 62 infliximab 62 zileuton 62 vemurafenib 62 plus gemcitabine 62 RAPAFLO 62 oxycodone CR 62 Tavocept 62 Aptivus ® 62 Clolar 62 DMARD 62 Emselex 62 octreotide LAR 62 PEGylated Fab fragment 62 LEXIVA 62 BAY #-# 62 TREANDA 62 placebo dexamethasone 62 comparator arm 62 LIALDA 62 placebo controlled studies 62 TNF alpha inhibitor 62 pazopanib 62 systemic lupus erythematosus SLE 62 Atacand 62 NATRECOR R 62 Vimpat ® 62 patients evaluable 62 Firazyr 62 TMC# [001] 62 CERVARIX 62 STELARA ™ 62 KRN# 62 cabazitaxel 62 REYATAZ R 62 Tolvaptan 62 post menopausal osteoporosis 62 clodronate 62 Fampridine SR 62 CoFactor 62 ruboxistaurin 62 lopinavir r arm 62 Vaprisol 62 Phase 2b clinical 62 RRMS patients 62 FASLODEX 62 ixabepilone 62 pioglitazone HCl 62 infusional 5-FU/LV 62 rasagiline tablets 62 crizotinib PF # 62 Vfend 62 Cladribine Tablets 62 relapsed refractory multiple myeloma 62 GAMMAGARD 62 Ocrelizumab 62 biologic DMARD 62 Peg IFN 62 TYGACIL 62 monotherapy 62 ganetespib 62 ofatumumab 62 sitagliptin 62 Romiplostim 62 paliperidone palmitate 62 Sym# 62 PEGINTRON TM 62 peginterferon alfa 2a 62 huC# DM4 62 invasive candidiasis 62 mg BID 62 Aflibercept 62 Ustekinumab 62 atazanavir sulfate 62 CYT# 62 odanacatib 62 Elagolix 62 phase IIb clinical 62 iniparib 62 Menveo 62 Gemzar ® 62 Arixtra 62 lasofoxifene 62 Zolinza 62 tolerability 62 Phase 2a clinical 62 ankylosing spondylitis AS 62 temsirolimus 62 phase IIa clinical 62 postherpetic neuralgia 62 ACTOS 62 Sandostatin LAR 62 LUX Lung 62 FOLOTYN 62 LY# [003] 62 mg QD 62 Certican 62 iclaprim 62 placebo controlled clinical trials 62 BRAF inhibitor 62 ocrelizumab 62 pramipexole 62 edoxaban 62 VPRIV 62 Phase III placebo controlled 62 zalutumumab 62 silodosin 62 oral diclofenac 62 Ophena TM 62 pharmacokinetic PK 62 Randomized Phase 62 MACUGEN 62 Cimzia 62 amifostine 62 pomalidomide 62 Ilaris 62 fenofibrate 62 ponatinib 62 telmisartan 62 rituximab 62 Phase 2a trial 62 ticagrelor 61 PegIntron 61 ORENCIA 61 COMFORT II 61 nitazoxanide 61 anti TNF alpha 61 OncoVEX GM CSF 61 Tiotropium 61 Ventavis 61 LAF# 61 AGILECT R 61 etravirine 61 Pivotal Phase III 61 phase IIb 61 Alemtuzumab 61 NLX P# 61 TNF antagonists 61 Taxotere R 61 R#/MEM 61 Azixa 61 SIMPONI 61 Bronchitol 61 Natalizumab 61 PEGylated interferon beta 1a 61 Welchol 61 Azedra 61 Tanespimycin 61 Cetrorelix 61 Afinitor ® 61 sunitinib 61 angiogenesis inhibitor 61 diarrhea predominant irritable 61 Arcalyst 61 Mipomersen 61 TRILIPIX 61 valsartan 61 Ambrisentan 61 ONGLYZA ™ 61 perampanel 61 alfa 2a 61 prucalopride 61 JANUMET 61 clopidogrel Plavix 61 Tamibarotene 61 DMARDS 61 SCH # 61 FOLFIRI 61 Cimzia certolizumab pegol 61 Pentacel vaccine 61 ZOSTAVAX 61 retinal vein occlusion 61 COPEGUS 61 ciclesonide 61 INC# 61 INCB# [001] 61 relapsing forms 61 Nplate 61 Vidaza azacitidine 61 mcg QD 61 muraglitazar 61 MERLIN TIMI 61 MoxDuo IR 61 Neupro R 61 idraparinux 61 Vimpat R 61 8mg/kg 61 EOquin TM 61 REVLIMID ® 61 ProSavin 61 Ostarine 61 FOLFOX4 61 everolimus 61 TEMODAL 61 Aptivus 61 terlipressin 61 BARACLUDE 61 Restless Legs Syndrome RLS 61 NEXIUM 61 tolerability profile 61 constipation OIC 61 Neulasta ® 61 albinterferon alfa 2b 61 raltegravir 61 OMNARIS Nasal Spray 61 ramelteon 61 interferon gamma 1b 61 rosuvastatin calcium 61 Boceprevir 61 BRIM3 61 Engerix B 61 RAPAFLO R 61 Hepsera 61 DAPT 61 pregabalin 61 standard chemotherapy regimen 61 acyclovir Lauriad R 61 docetaxel Taxotere R 61 mapatumumab 61 HBeAg positive patients 61 Everolimus 61 methylnaltrexone bromide 61 Rebif ® 61 TAXUS Stent 61 NEVO ™ 61 talactoferrin 61 SYMBICORT 61 SPRYCEL 61 Targretin 61 REVLIMID R 61 Microplasmin 61 Lamictal XR 61 recurrent glioblastoma multiforme 61 ATL/TV# 61 solifenacin 61 Ixempra 61 Durezol 61 mg dose 61 interferon beta 1b 61 dacetuzumab 61 Valsartan 61 UPLYSO 61 ONTARGET 61 vildagliptin 61 Zarnestra 61 fluvastatin 61 fostamatinib 61 thromboembolic events 61 REVLIMID 61 FROVA 61 antibody MAb 61 Promacta 61 candesartan 61 tapentadol ER 61 ARCALYST ® 61 Pivotal Phase 61 Lialda 61 phase IIb trial 61 ZYVOX 61 CYPHER Stent 61 ELND# 61 CYCLOSET 61 SAPHRIS 61 denosumab 61 phase IIa 61 Eltrombopag 61 Toviaz 61 enzastaurin 61 vidofludimus 61 esomeprazole 61 headache nasopharyngitis 61 relapsed multiple myeloma 61 alemtuzumab treated 61 AVONEX 61 RSD# oral 61 febrile neutropenia 61 brivaracetam 61 Duloxetine 61 Trastuzumab 61 NP2 Enkephalin 61 GAMMAGARD LIQUID 61 docetaxel Taxotere ® 61 Tracleer R 61 triamcinolone 61 vorinostat 61 nonrandomized 61 cilengitide 61 Raptiva R 61 erlotinib Tarceva ® 60 phase IIb study 60 Certolizumab pegol 60 ROTARIX 60 Xyrem ® 60 bendamustine 60 peg IFN 60 atypical antipsychotic medication 60 tafamidis 60 aprepitant 60 evaluable patients 60 metformin HCl 60 AVONEX ® 60 Diabetic Macular Edema 60 primary generalized tonic 60 motesanib 60 intravenous bisphosphonates 60 olmesartan 60 multicenter Phase 60 endophthalmitis 60 tasocitinib 60 candesartan cilexetil 60 abatacept Orencia 60 hypercalcemia 60 TNF Tumor Necrosis Factor 60 rufinamide 60 Phase IIIb study 60 AMITIZA 60 JAK Inhibitor 60 Sprycel dasatinib 60 TNF inhibitor 60 amrubicin 60 leukemia AML 60 Atrasentan 60 evaluating tivozanib 60 FOSRENOL 60 FOLOTYN ® 60 PEGASYS ® 60 ibandronate 60 LIVALO 60 painful diabetic neuropathy 60 SNT MC# 60 Tasimelteon 60 tgAAC# 60 INTEGRILIN 60 JAK inhibitor 60 mGluR5 negative 60 Diovan HCT 60 mitoxantrone 60 Exjade 60 regadenoson 60 Icatibant 60 fidaxomicin 60 FIRAZYR 60 esomeprazole Nexium 60 NVA# 60 ADAGIO study 60 cetuximab Erbitux 60 Belimumab 60 seropositive patients 60 proton pump inhibitor 60 Archexin 60 cIAI 60 MabThera rituximab 60 lomitapide 60 VA# [002] 60 homozygous familial hypercholesterolemia 60 oral ridaforolimus 60 Azilect ® 60 Mylotarg 60 STRIDE PD 60 achieved statistical significance 60 Irinotecan 60 FOSRENOL R 60 PRT# 60 Vectibix 60 Entereg R 60 TELINTRA 60 Rasagiline 60 vertebral fractures 60 efficacy tolerability 60 receiving golimumab 60 Topiramate 60 Revlimid lenalidomide 60 colesevelam HCl 60 Fibrillex TM 60 Viread Emtriva 60 IRESSA 60 UCB Cimzia 60 unstable angina UA 60 Hepatocellular Carcinoma HCC 60 disease modifying antirheumatic 60 secondary efficacy endpoints 60 Zelrix 60 osteoarthritis OA 60 clobazam 60 severe gastroparesis 60 Focalin XR 60 Herceptin trastuzumab 60 CA4P 60 multicenter Phase III 60 pramlintide 60 bosutinib 60 ZACTIMA 60 abiraterone acetate 60 Onbrez Breezhaler 60 OZURDEX ® 60 ALVESCO 60 Protelos 60 cutaneous T cell 60 randomized Phase IIb 60 MGd 60 fenofibric acid 60 chronic HCV infection 60 Diamyd ® 60 Afinitor 60 atacicept 60 darunavir r 60 post herpetic neuralgia PHN 60 TMS Therapy 60 valopicitabine 60 EVEREST II 60 tacrolimus ointment 60 diabetic gastroparesis 60 bevacizumab 60 Phase Ib clinical 60 non metastatic osteosarcoma 60 sorafenib 60 Victoza ® 60 Carfilzomib 60 pemetrexed Alimta 60 KAPIDEX 60 Teriflunomide 60 EDEMA3 60 peginterferon alfa 2a Pegasys 60 HoFH 60 TYSABRI 60 fampridine 60 NATRECOR ® 60 Phase IIIb 60 corticosteroid therapy 60 RLAI 60 Increlex R 60 ranolazine 60 Rituximab 60 Inhalation Solution 60 pemetrexed 60 ritonavir boosted 60 atherothrombotic events 60 rosuvastatin Crestor 60 secondary endpoint 60 purpura ITP 60 Phase IIb Trial 60 Naglazyme 60 intravitreal injection 60 SPRYCEL ® 60 LPV r 60 VELCADE melphalan 60 Remicade infliximab 60 antiepileptic drug 60 randomized multicenter 60 lapatinib 60 rotigotine transdermal patch 60 trabectedin 60 NXL# 60 irbesartan 60 QTc prolongation 60 myopathy rhabdomyolysis 60 LEVADEX 60 pediatric Crohn disease 60 diarrhea nausea fatigue 60 Monotherapy 60 dosage regimens 60 deferiprone 60 salmeterol inhalation powder 60 PD LID 60 Telaprevir 60 safinamide 60 BARACLUDE R 60 Laquinimod 60 ABC/3TC 60 relapsing MS 60 VIRAMUNE 60 tamsulosin 60 Ramelteon 60 PRADAXA 60 Xcytrin 60 BARACLUDE ® 60 APTIVUS R 60 SPIRIVA HandiHaler 60 mertansine 60 exenatide injection 60 direct renin inhibitor 60 Zorbtive TM 60 KETEK 60 TNF antagonist 60 pegylated interferon alpha 60 IBS C 60 certolizumab 60 Ranolazine 60 rFVIIIFc 60 boosted protease inhibitor 60 levosimendan 60 MPS VI 59 Resten NG 59 diabetic macular edema DME 59 omalizumab 59 vicriviroc 59 morphometric vertebral fractures 59 eszopiclone 59 oral prodrug 59 bevacizumab Avastin ® 59 Linagliptin 59 atrasentan 59 gemifloxacin 59 peginterferon 59 Eculizumab 59 brand ciclesonide HFA 59 primary hypercholesterolemia 59 daptomycin 59 AIR CF2 59 tiotropium bromide 59 briakinumab 59 Phase 1b 59 double blinded placebo 59 AZILECT ® 59 alpha interferons 59 Victoza R 59 Pemetrexed 59 INCB# [002] 59 delayed CINV 59 cardiac toxicity 59 pegylated interferon alfa 2b 59 telaprevir 59 Pioglitazone 59 discontinuations due 59 Potiga 59 generalized anxiety disorder GAD 59 linagliptin 59 Elitek 59 dronedarone 59 tezampanel 59 arzoxifene 59 HGS# 59 Bosentan 59 GABITRIL 59 COMBIVIR 59 Neurodex 59 ximelagatran 59 DDP# 59 antiplatelet agent 59 dutasteride 59 Proxinium TM 59 lenalidomide Revlimid R 59 dose escalation Phase 59 EVIZON 59 aripiprazole 59 ACIPHEX 59 COPAXONE ® 59 LITHE 59 Degarelix 59 PRE SURGE 59 Tygacil 59 ELADUR 59 Tasigna nilotinib 59 dose limiting toxicities 59 EFFEXOR XR 59 Locteron 59 Triolex 59 peginterferon alfa 2b 59 LymphoStat B belimumab 59 desvenlafaxine 59 TAXUS Liberte Stent 59 Nexavar ® 59 Prestara 59 events SAEs 59 Coronary Stent 59 Long Term Efficacy 59 Stelara 59 VIMOVO 59 chronic ITP 59 Phase #/#a 59 cangrelor 59 Parkinson disease levodopa induced 59 LibiGel ® 59 olanzapine LAI 59 Vivaglobin 59 PXD# 59 aflibercept 59 acute HAE attacks 59 postoperative ileus POI 59 T DM1 59 μg dose 59 INVEGA R 59 QNEXA 59 Esbriet ® 59 trabedersen 59 Pegasys R 59 afatinib 59 HuMax CD4 59 phase IIIb 59 TNF blocker 59 Doxil ® 59 ROTATEQ 59 composite endpoint 59 Nexavar sorafenib 59 Ozarelix 59 tolerability profiles 59 imatinib 59 sJIA 59 trospium 59 REMINYL ® 59 TNF inhibitors 59 pegylated liposomal doxorubicin 59 dexpramipexole 59 investigational drug 59 LUCENTIS 59 multicenter placebo controlled 59 ZETIA 59 NGX# 59 lumiliximab 59 RANK Ligand inhibitor 59 gastrointestinal stromal tumors GIST 59 MAGE A3 ASCI 59 elevated intraocular pressure 59 LHON 59 Instanyl 59 phase Ib 59 Advagraf 59 Clolar ® 59 acute coronary syndromes ACS 59 NeuroStar TMS Therapy 59 NEUPOGEN 59 Arranon 59 Safinamide 59 QLT# 59 XELOX 59 Telmisartan 59 relapsed myeloma 59 Enbrel etanercept 59 Tarceva 59 INTRON 59 tenofovir emtricitabine 59 hyperphenylalaninemia HPA due 59 Afatinib 59 Hycamtin ® 59 virus HCV protease inhibitor 59 favorable tolerability 59 Tekturna HCT 59 BYDUREON 59 XmAb# 59 ELOXATIN 59 neurogenic orthostatic hypotension 59 BoNTA 59 glufosfamide 59 EUFLEXXA R 59 idiopathic pulmonary fibrosis IPF 59 phase 2a 59 VIDAZA 59 talabostat 59 Phase 1b clinical 59 multi kinase inhibitor 59 atypical antipsychotic 59 clevidipine 59 darunavir 59 Serdaxin 59 Rituxan 59 Phase IIb trials 59 cSSSI 59 Phase IIa clinical 59 PRIALT 59 pulmonary arterial hypertension PAH 59 interferon alfa 59 MEVACOR 59 Avastin bevacizumab 59 HQK 59 Dupuytren Contracture 59 carboplatin paclitaxel 59 INVEGA ® 59 aliskiren 59 INTEGRILIN R 59 PF # [001] 59 Rheumatoid Arthritis RA 59 cilostazol 59 PREOS 59 alpha blocker 59 eniluracil 59 Zenvia 59 low dose cytarabine 59 Fablyn 59 Amplimexon 59 blepharospasm 59 Paxil paroxetine 59 confirmatory Phase III 59 azathioprine 59 VICTRELIS 59 Endeavor Resolute DES 59 quetiapine fumarate 59 TAXUS TM 59 post operative ileus 59 ACOMPLIA R 59 Ozurdex 59 Phase Ib 59 TAXUS stent 59 DMARDs 59 cell lymphoma CTCL 59 renal toxicity 59 pregabalin Lyrica 59 dasatinib Sprycel ® 59 Zometa zoledronic acid 59 Methylnaltrexone 59 ACR# response 59 Genasense ® 59 Plicera 59 sodium thiosulfate STS 59 BENICAR HCT 59 ziprasidone Geodon 59 investigational protease inhibitor 59 Rasilez ® 59 Rilonacept 59 VFEND 59 etanercept Enbrel 59 MYDICAR ® 59 Cethromycin 59 MabThera 59 nebulized formoterol fumarate 59 Betaferon 59 delayed onset CINV 59 metastatic RCC 59 galiximab 59 ALT flares 59 SNRI 59 Metastatic Colorectal Cancer 59 MabThera Rituxan 59 Xinlay 59 inhibitor RG# 59 receptor tyrosine kinase inhibitor 59 prospective multicenter 59 DexaSite 59 GW# [003] 59 CAMMS# 59 REYATAZ ® 59 SEBIVO 59 Phase IIa trial 59 Sabril 59 CAELYX 59 belatacept 59 Edoxaban 59 IPX# 59 BYETTA ® 59 romidepsin 59 GFT# 59 Epratuzumab 59 Bortezomib 59 VEGF Trap Eye 59 Tekamlo 59 dalfampridine 59 partial onset seizures 59 ALVESCO HFA 59 Acute Ischemic Stroke 59 Prostate AdenoCarcinoma Treatment